Establishment and application of a visual nucleic acid detection method for parvovirus [PDF]
Parvoviruses pose a significant threat to the livestock breeding industry, leading to high morbidity and mortality rates. Rapid, accurate, and convenient detection methods are crucial for early intervention and control of parvovirus infection. This study
Shaoting Weng +9 more
doaj +2 more sources
Systemic inflammatory response syndrome: a risk factor associated with poor prognosis of dogs infected with canine parvovirus 2 [PDF]
: Canine parvovirus 2 (CPV-2) is a highly contagious enteric virus that causes high morbidity and mortality, especially in dogs under six months of age.
Tuane Ferreira Melo +8 more
doaj +1 more source
Associations between early life exposure to parvovirus and antibiotic treatment and the occurrence and severity of later chronic enteropathy in dogs. [PDF]
Abstract Background Canine parvovirus (CPV) infection is reportedly associated with chronic enteropathy (CE), but infected puppies are often treated with antibiotics, which may also promote CE. This study aims to compare the presence and severity of CE among dogs that were CPV‐infected, treated with antibiotics or healthy during puppyhood.
Kuzi S, Goldstein N, Sutton G, Segev G.
europepmc +2 more sources
First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. [PDF]
A synthetic peptide vaccine which protects dogs against challenge with virulent canine parvovirus is described. The amino acid sequence used was discovered in previous studies on the immunogenic properties of previously mapped antigenic sites and ...
Casal, J.I. +9 more
core +14 more sources
A Case of Sepsis Caused by ST80 Multidrug-Resistant Enterococcus faecium With Concurrent Klebsiella pneumoniae Infection in a Dog. [PDF]
An 8‐year‐old dog developed acute respiratory distress that progressed to sepsis and death. Multidrug‐resistant Enterococcus faecium ST80 was isolated from the liver and kidney, while Klebsiella pneumoniae was detected in the lung by PCR. Whole‐genome sequencing showed that the ST80 isolates were genetically identical, suggesting hematogenous spread ...
Seo HM +5 more
europepmc +2 more sources
Immunohistochemical diagnostic characteristics of parvovirus infection in dogs
Thе current study goal was to compare the results from the histopathological and immunohistochemical findings in dogs that have previously been clinically diagnosed with parvovirus infection.
Ivica Gjurovski +5 more
doaj +1 more source
Canine parvovirus enteritis: epidemic situation analysis and perspectives
Parvovirus enteritis is one of canine dangerous diseases which poses a particular concern for practitioners and dog owners around the world. Parvovirus type 2 (CPV-2) can affect dogs at any age, but puppies between 6 weeks and 6 months old are most ...
T. S. Galkina, A. К. Karaulov
doaj +1 more source
Novel parvoviruses from wild and domestic animals in Brazil provide new insights into parvovirus distribution and diversity [PDF]
Parvoviruses (family Parvoviridae) are small, single-stranded DNA viruses. Many parvoviral pathogens of medical, veterinary and ecological importance have been identified.
de Araujo, Jansen +16 more
core +7 more sources
Haematological, oxidative stress and electrolyte alterations in puppies with canine parvoviral enteritis [PDF]
Haematological changes, oxidative stress markers and electrolyte alterations were evaluated in puppies infected with canine parvovirus type 2 (CPV-2) that were presented to veterinary hospitals and clinics in South Eastern, Nigeria.
Chigozie Ukwueze +4 more
doaj +1 more source
Isolation, Identification and Phylogenetic Analysis of Canine Parvovirus Type 2c in Two Regions of Iran. [PDF]
Canine parvovirus Type 2c (CPV‐2c) was isolated from infected dogs in Iran and identified through VP2 gene sequencing. Phylogenetic analysis revealed close genetic links to Asian and African strains. A novel L583I mutation was detected, warranting further investigation into its impact on viral antigenicity and vaccine efficacy.
Barzegar A +3 more
europepmc +2 more sources

